These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23582237)

  • 1. Performance of Sino-implant (II) in routine service delivery in Madagascar.
    Feldblum PJ; Hanitriniaina O; Lendvay A; Hopkins K; Wheeless A; Chen M; Steiner MJ
    Contraception; 2013 Jul; 88(1):103-8. PubMed ID: 23582237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness, safety and acceptability of Sino-implant (II) during the first year of use: results from Kenya and Pakistan.
    Lendvay A; Otieno-Masaba R; Azmat SK; Wheeless A; Hameed W; Shaikh BT; Kuria S; Steiner MJ; Chen M; Feldblum PJ
    Contraception; 2014 Mar; 89(3):197-203. PubMed ID: 24439674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implant removal experience with Sino-implant (II) at four Chinese sites.
    Cheng L; Steiner MJ; Meng H; Luo D; Zhong Y; Cheng Y; Chen G; Ni H; Feldblum PJ
    Contraception; 2014 Sep; 90(3):249-52. PubMed ID: 24965314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient satisfaction with a levonorgestrel-releasing contraceptive implant. Reasons for and patterns of removal.
    Haugen MM; Evans CB; Kim MH
    J Reprod Med; 1996 Nov; 41(11):849-54. PubMed ID: 8951137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake of the levonorgestrel intrauterine system among recent postpartum women in Kenya: factors associated with decision-making.
    Hubacher D; Masaba R; Manduku CK; Veena V
    Contraception; 2013 Jul; 88(1):97-102. PubMed ID: 23566383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability of the levonorgestrel releasing-intrauterine system and etonogestrel implant: one-year results of an observational study.
    Short M; Dallay D; Omokanye S; Hanisch JU; Inki P
    Eur J Contracept Reprod Health Care; 2012 Feb; 17(1):79-88. PubMed ID: 22200172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cytology associated with levonorgestrel contraception.
    Misra JS; Engineer AD; Tandon P
    Acta Cytol; 1995; 39(1):45-9. PubMed ID: 7847008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Kenyan women in a prospective cohort study who continue using subdermal contraceptive implants at 12 months.
    O'Neill E; Tang J; Garrett J; Hubacher D
    Contraception; 2014 Mar; 89(3):204-8. PubMed ID: 24360643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implant contraception in Singaporean women: one decade of experience in KK Women's and Children's Hospital.
    Kang W; Tan KH
    Singapore Med J; 2004 Oct; 45(10):482-6. PubMed ID: 15455169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
    Wildemeersch D; Janssens D; Andrade A
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonmenstrual adverse events associated with subdermal contraceptive implants containing normegestrel and levonorgestrel.
    Arowojolu AO; Ladipo OA
    Afr J Med Med Sci; 2003 Mar; 32(1):27-31. PubMed ID: 15030062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data.
    Meirik O; Brache V; Orawan K; Habib NA; Schmidt J; Ortayli N; Culwell K; Jackson E; Ali M;
    Contraception; 2013 Jan; 87(1):113-20. PubMed ID: 23063337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers.
    Polaneczky M; Slap G; Forke C; Rappaport A; Sondheimer S
    N Engl J Med; 1994 Nov; 331(18):1201-6. PubMed ID: 7935659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twelve month follow-up of a contraceptive implant outreach service in rural Papua New Guinea.
    Gupta S; Mola G; Ramsay P; Jenkins G; Stein W; Bolnga J; Black K
    Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):213-218. PubMed ID: 28401563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study on the acceptability of levonorgestrel-releasing intrauterine device by young, single, nulliparous Chinese females following surgical abortion.
    Li CF; Lee SS; Pun TC
    Contraception; 2004 Mar; 69(3):247-50. PubMed ID: 14969674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sino-implant (II)--a levonorgestrel-releasing two-rod implant: systematic review of the randomized controlled trials.
    Steiner MJ; Lopez LM; Grimes DA; Cheng L; Shelton J; Trussell J; Farley TM; Dorflinger L
    Contraception; 2010 Mar; 81(3):197-201. PubMed ID: 20159174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing unintended pregnancy among young women in Kenya: prospective cohort study to offer contraceptive implants.
    Hubacher D; Olawo A; Manduku C; Kiarie J; Chen PL
    Contraception; 2012 Nov; 86(5):511-7. PubMed ID: 22633247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levonorgestrel contraceptive implants in female patients 14 to 21 years old.
    Suman VJ; Van Winter JT; Evans MP; Simmons PS; Jacobsen SJ; Manolis AL
    Mayo Clin Proc; 1998 Jan; 73(1):10-6. PubMed ID: 9443673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety of Sino-implant (II) for women with medical conditions or other characteristics: a systematic review.
    Phillips SJ; Steyn PS; Curtis KM
    Contraception; 2016 Sep; 94(3):216-25. PubMed ID: 27217053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems.
    Wildemeersch D; Janssens D; Vrijens M; Weyers S
    Contraception; 2005 Jun; 71(6):465-9. PubMed ID: 15914138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.